Quizartinib has been approved for the treatment of a specific type of genetic mutation. Which mutation does Quizartinib target, and which other medications is it used in combination with?
1: FLT3/ITD mutation; sorafenib and midostaurin
2: BRAF mutation; vemurafenib and dabrafenib
3: KRAS mutation; cetuximab and panitumumab
4: EGFR mutation; erlotinib and gefitinib